Results 121 to 130 of about 152,537 (266)

Long-term incidence and predictors of in-stent restenosis after chronic total occlusion percutaneous coronary intervention: a cohort study. [PDF]

Int J Cardiol Heart Vasc
Mansikkaniemi L, Stewart JA, Sinisalo J, Holmström M, Laine P.   +4 more
europepmc   +1 more source

Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The prognostic benefit of revascularization for unprotected left main (LM) disease remains uncertain, as guideline endorsement of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) precludes comparison with deferral, which is unlikely to be assessed in a randomized trial.
Marc Meller Bröchner, Evald Høj Christiansen, Kristian Kragholm, Lisette Okkels Jensen, Gennady Atroshchenko, Ivy Susanne Modrau, Lars Riber, Oliver Buchhave Pedersen, Leif Thuesen, Christian Torp‐Pedersen, Ashkan Eftekhari   +10 more
wiley   +1 more source

Spatial Mismatch Between Angiographic Obstruction and Plaque Destabilization in Acute Coronary Syndromes: A Conceptual Narrative Review

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The identification of the “culprit lesion” in acute coronary syndromes (ACS) traditionally relies on coronary angiography, assuming that the most severe stenosis, abrupt occlusion, or largest filling defect marks the site of plaque destabilization.
Fernando Quevedo‐Candela, Olivier F. Bertrand, Pedro Cepas‐Guillén, Jean‐Pierre Déry, David García‐Labbé, Andrés Ruhl, Eduardo Flores‐Umanzor, Tomas Cieza   +7 more
wiley   +1 more source

Successful removal of a biliary metal stent using the stent-in-stent-in-stent technique

Endoscopy, 2023
Masato Matsuyama, Takeshi Okamoto, Tsuyoshi Takeda, Akiyoshi Kasuga, Takashi Sasaki, Masato Ozaka, Naoki Sasahira   +6 more
openaire   +2 more sources

Mechanisms and Management of Acquired Aseptic Intracardiac Communications After Transcatheter Aortic Valve Implantation: Single‐Center Case Series Insights

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Acquired aseptic intracardiac communications (AICCs) are rare but clinically relevant structural complications following transcatheter aortic valve implantation (TAVI), typically resulting from mechanical injury to the aortic annulus, interventricular septum, or adjacent structures.
Geza Fontos, Abdelkrim Ahres, Marton Vertesaljai, Tunde Pinter, Zsolt Piroth, Matyas Pal, Peter Andreka   +6 more
wiley   +1 more source

A simple yet novel solution to prevent stent stripping in Guidezilla use

Anatolian Journal of Cardiology, 2020
Kerim Esenboga, Kaan Akın, Nil Ozyuncu, Turkan Seda Tan, Durmus Eralp Tutar   +4 more
doaj   +1 more source

Retrieval of migrated pancreatic stent: “stent-in-stent” technique [PDF]

Endoscopy, 2015
Yalaka R, Reddy, Harpal S, Dhaliwal, Pankaj, Gupta, Saroj K, Sinha, Rakesh, Kochhar   +4 more
openaire   +2 more sources

Intravascular Lithotripsy in Left Main Stem Percutaneous Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background IVL is increasingly used for coronary calcium modification; however, prospective data for its use in LMS lesions are lacking. Aims To evaluate the feasibility, safety, and mechanical efficacy of intravascular lithotripsy (IVL) for calcium modification in calcified distal left main stem (LMS) percutaneous coronary intervention ...
Claudia S Cosgrove, Retesh Bajaj, Ganeev Malhotra, Francis R Joshi, Akiko Maehara, Andrew McNeice, Margaret McEntegart, Gao Ong, Novalia Sidik, Julian W Strange, Simon Walsh, Ian Webb, Simon Wilson, Jiawei Wu, James C Spratt   +14 more
wiley   +1 more source

Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton, Ben Peterson, Brian Whisenant, Anwar Tandar   +3 more
wiley   +1 more source

Biolimus- versus sirolimus-eluting stents in percutaneous coronary intervention: a comprehensive systematic review and meta-analysis of randomised controlled trials. [PDF]

AsiaIntervention
Suruagy-Motta RFO, Dexheimer da Silva L, Rezende Neves G, Farias CA, Galvão de Oliveira Oldra L, Machado Gomes de Sousa PA, Damiani Bertoli E, Martins Filho E, Cox-Alomar P, Pileggi B, Craveiro de Melo P, de Andrade Nunes D, Azzalini L, Kumar S.   +13 more
europepmc   +1 more source